Dergiler / Journal of Pharmaceutical Technology / 2020 / Cilt: 1 - Sayı: 1

Posaconazole loaded ocular inserts for antifungal activity

Sayfa
1–6
Yayın Tarihi
2020-04-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Analyses results revealed that chitosan-based ocular inserts were suitable systems for posaconazole delivery for the treatment of severe ocular fungal infections.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Corneal and conjunctival infections are common ocular diseases; however, sometimes lead to blindness when neglected.
📊
Temel Bulgular & Veri:The present study was carried out to demonstrate that ocular inserts effectively delivers a significant concentration of drug with topical administration for the treatment of fungal infections with the help of extended residence time on the ocular surface.
💡
Sonuç & Katkı:Analyses results revealed that chitosan-based ocular inserts were suitable systems for posaconazole delivery for the treatment of severe ocular fungal infections.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Chitosan · In-Vitro Release · Ocular Bioavailability

Abstract

Corneal and conjunctival infections are common ocular diseases; however, sometimes lead to blindness when neglected. Despite most of the ocular drug delivery systems are in eye drop form, they suffer from poor retention on the ocular surface and low ocular bioavailability leading to unsatisfactory results even with repeated treatment. Therefore, there is a need for more effective drug delivery systems for the ocular application. The present study was carried out to demonstrate that ocular inserts effectively delivers a significant concentration of drug with topical administration for the treatment of fungal infections with the help of extended residence time on the ocular surface. Chitosan-based inserts were prepared by the freeze-drying method. The prepared inserts were evaluated for various parameters. Layered structures were revealed with scanning electron microscopy analyses. Thermal and structural behaviors were analyzed by differential scanning calorimetry and Fourier-transform infrared spectroscopy with nuclear magnetic resonance analyses, respectively. Drug contents were evaluated by a validated HPLC method. In vitro release studies were also performed in simulated tear fluid at 34±1°C for 48 hours. Analyses results revealed that chitosan-based ocular inserts were suitable systems for posaconazole delivery for the treatment of severe ocular fungal infections.

🔖

Bu Makaleye Atıf Yap

AYKAÇ, K., YENİLMEZ, E., DEMİREL, M., BAŞARAN, E. (2020). Posaconazole loaded ocular inserts for antifungal activity. Journal of Pharmaceutical Technology, Cilt: 1 - Sayı: 1, 1–6. https://ajindex.com/articles/836562

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Chaudhari P, Ghate VM, Lewis SA. Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics. Exp Eye Res. (2019); 189: 107829.
  2. Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World J Pharmacol. (2013); 2: 47-64.
  3. Krishnaswami V, Kandasamy R, Alagarsamy S, Palanisamy R, Natesan S. Biological macromolecules for ophthalmic drug delivery to treat ocular diseases. Int J Biol Macromol. (2018); 110: 7-16.
  4. Kalkancı A, Özdek Ş. Ocular fungal infections. Curr Eye Res. (2011); 36(3): 179-189.
  5. Başaran E, Yenilmez E, Berkman MS, Büyükköroğlu G, Yazan Y. Chitosan nanoparticles for ocular delivery of cyclosporine A. J Microencapsul. (2014); 31(1): 49-57.
  6. Başaran E, Yazan Y. Ocular application of chitosan. Expert Opin Drug Del. (2012); 9(6):701-712.
  7. Franca JR, Foureaux G, Fuscaldi LL, Ribeiro TG, Castilho RO, Yoshid MI, Cardoso VN, Fernandes SOA, Cronemberger S, Nogueira JC, Ferreira AJ, Faraco AAG. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation. Int J Pharm. (2019); 570: 118662.
  8. Ludwig, A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. (2005); 57: 1595-1639.
  9. Muxika A, Etxabide A, Uranga J, Guerrero P, de la Caba K. Chitosan as a bioactive polymer: Processing, properties and applications. Int J Biol Macromol. (2017); 105: 1358-1368.
  10. Kalantari K, Afifi AM, Jahangirian H, Webster TJ. Biomedical applications of chitosan electrospun nanofibers as a green polymer. Carbohyd Polym. (2019); 207: 588–600.
  11. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan-A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. (2011); 36: 981-1014.
  12. De Campos, AM, Sánchez A, Alonso MJ. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. (2001); 224: 15